The balanced answer
Clinical trials and systematic reviews of mesenchymal stromal cell (MSC) therapy have generally reported an acceptable short-term safety profile, with transient side effects being most common. PubMed: MSC safety meta-analyses. At the same time, regulators have documented serious harms from unapproved products and unsafe clinics. Both statements are true, and the difference lies largely in product quality, technique and patient selection.
Common side effects
| Type | What to expect | How long |
|---|---|---|
| Joint or tendon injection | Pain, swelling, stiffness, bruising | Usually 2 to 7 days |
| Fat or bone marrow harvest (autologous) | Soreness and bruising at the harvest site | Several days to two weeks |
| IV infusion | Mild fever, chills, headache, fatigue | Usually 24 to 48 hours |
Serious but uncommon risks
- Infection at the injection site or in the bloodstream, mainly linked to contamination or poor sterile technique.
- Allergic or immune reactions, particularly with donor products.
- Blood clots or embolism with IV infusions, particularly if cells are poorly prepared.
- Abnormal tissue growth, reported after some unregulated treatments.
- Nerve or blood vessel injury from inaccurate injections.
- Vision loss: a well-known report described severe vision loss in patients who received fat-derived “stem cell” injections into the eye at an unregulated clinic. PubMed
The US FDA explains these risks in its consumer warning about stem cell therapies.
What makes stem cell therapy safer?
- Proper diagnosis and patient selection, with imaging reviewed by a doctor before treatment.
- Quality-controlled cells with donor screening, sterility, endotoxin and viability testing. Cells used in our programs are prepared in ISO 9001:2015-certified partner laboratories.
- Image-guided injections for joints and spine.
- Licensed doctors working in a clinical setting with emergency equipment.
- Honest consent that explains risks and evidence.
- Follow-up, so problems are detected early.
Our safety page describes how we apply these, and the clinic checklist helps you assess any provider.
Who should not have stem cell therapy?
- Active cancer or recent cancer, unless cleared by an oncologist.
- Active infection.
- Pregnancy or breastfeeding.
- Uncontrolled bleeding disorders or anticoagulants that cannot be safely managed.
- Severe uncontrolled heart, kidney or liver disease (especially for IV treatment).
- Unrealistic expectations, such as hoping for a cure.
Safety of travelling for treatment
Travel adds its own risks: long flights increase blood clot risk, follow-up can be harder, and insurance may not cover complications. Plan rest days, move during flights and arrange follow-up with your home doctor. See stem cell therapy abroad: a planning guide and aftercare.
Exosomes and PRP: are they safer?
PRP uses your own blood, so donor risks are absent. Exosomes contain no living cells, which avoids some cell-related risks, but product quality varies widely. See exosomes vs stem cells.
Get a safety-first review
Send your MRI and medical reports, including your medication list, on WhatsApp. A doctor will check whether treatment is likely to be safe and sensible for you, and will tell you if it is not.
Frequently asked questions
What are the side effects of stem cell therapy?
Common side effects are pain, swelling and stiffness at the injection site for a few days, and after IV infusion, mild fever, headache or tiredness. Most settle without treatment.
Can stem cell therapy cause cancer?
Mesenchymal cell trials have not shown a clear cancer signal, but long-term data are limited. Tumour-like growths have been reported after poorly controlled treatments. People with active cancer are generally excluded.
Has anyone been harmed by stem cell therapy?
Yes. Published reports include blindness after eye injections at unregulated clinics, infections from contaminated products and abnormal growths. Most occurred with untested products or unsafe practices.
Is stem cell therapy safe for older people?
Age alone is not a barrier, but older patients more often have heart, kidney or clotting issues that affect safety. A doctor should review your full history and medications first.
Are umbilical cord stem cells safe?
Umbilical cord-derived MSCs have been used in many trials with a generally acceptable short-term safety profile. Safety depends on donor screening and laboratory testing for each batch.
This page is general information, not medical advice, and does not replace a consultation with your own doctor. Results vary and no treatment outcome can be guaranteed. We are a patient coordination service and may receive a referral fee from partner medical providers. See our medical disclaimer and referral disclosure.